Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

  1. Sáez-Llorens, X.
  2. Norero, X.
  3. Mussi-Pinhata, M.M.
  4. Luciani, K.
  5. de la Cueva, I.S.
  6. Díez-Domingo, J.
  7. Lopez-Medina, E.
  8. Epalza, C.
  9. Brzostek, J.
  10. Szymański, H.
  11. Boucher, F.D.
  12. Cetin, B.S.
  13. De Leon, T.
  14. Dinleyici, E.C.
  15. Gabriel, M.ÁM.
  16. Ince, T.
  17. Macias-Parra, M.
  18. Langley, J.M.
  19. Martinón-Torres, F.
  20. Rämet, M.
  21. Kuchar, E.
  22. Pinto, J.
  23. Puthanakit, T.
  24. Baquero-Artigao, F.
  25. Gattinara, G.C.
  26. Arribas, J.M.M.
  27. Ramos Amador, J.T.
  28. Szenborn, L.
  29. Tapiero, B.
  30. Anderson, E.J.
  31. Campbell, J.D.
  32. Faust, S.N.
  33. Nikic, V.
  34. Zhou, Y.
  35. Pu, W.
  36. Friel, D.
  37. Dieussaert, I.
  38. Lopez, A.G.
  39. McPhee, R.
  40. Stoszek, S.K.
  41. Vanhoutte, N.
  42. Montrer des auteurs +
Revue:
The Journal of infectious diseases

ISSN: 1537-6613

Année de publication: 2024

Volumen: 229

Número: 1

Pages: 95-107

Type: Article

DOI: 10.1093/INFDIS/JIAD271 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus